Menopause Research and Equity Act of 2023

The Menopause Research and Equity Act of 2023 requires the National Institutes of Health (NIH) to evaluate existing and ongoing research on menopause, perimenopause, and mid-life women’s health, identifying gaps in knowledge and funding over the past five years. The NIH must then develop a strategic plan with health professionals (including specialists like gynecologists and endocrinologists) to address these gaps and guide future research on treatments for menopause symptoms. The bill also mandates new NIH research on causes, symptoms, and treatments for menopause-related health issues, including a study on hormonal treatments. All activities must be funded using existing NIH resources, with no new appropriations authorized. This aims to improve scientific understanding of women’s mid-life health needs.